Home

Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 23/11/21

Trade details

Type
Insider sale
Amount
$7,405.58
Shares · price
4,382 sh · $1.69 a share
Held after
874,906 sh
Trade date
23/11/20
Filed
23/11/21
Days to filing
1 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

Diana Brainard's recent trades

  • Diana Brainard

    SellKalaris Therapeutics

    $4,788

    Filed 24/11/20

  • Diana Brainard

    SellKalaris Therapeutics

    $9,124

    Filed 24/11/06

  • Diana Brainard

    SellKalaris Therapeutics

    $7,607

    Filed 24/10/23

  • Diana Brainard

    SellKalaris Therapeutics

    $1,209

    Filed 24/10/04

  • Diana Brainard

    SellKalaris Therapeutics

    $3,989

    Filed 24/08/22

Diana Brainard, CEO — sold $7,406 of Kalaris Therapeutics KLRS · 0.5% of holdings · 10b5-1 plan | Whalegun